loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Istaroxime, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Istaroxime

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Bora Pharmaceuticals- Making success more certain.

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    2D Structure
    1. Also known as: 203737-93-3, Istaroxime, (e)-, Pst-2744, W40687go3s, (3e,5s,8r,9s,10r,13s,14s)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione, 203738-46-9
    Molecular Formula
    C21H32N2O3
    Molecular Weight
    360.5  g/mol
    InChI Key
    MPYLDWFDPHRTEG-PAAYLBSLSA-N
    FDA UNII
    W40687GO3S
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3E,5S,8R,9S,10R,13S,14S)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione
    2.1.2 InChI
    InChI=1S/C21H32N2O3/c1-20-7-5-13(23-26-10-9-22)11-17(20)18(24)12-14-15-3-4-19(25)21(15,2)8-6-16(14)20/h14-17H,3-12,22H2,1-2H3/b23-13+/t14-,15-,16-,17+,20+,21-/m0/s1
    2.1.3 InChI Key
    MPYLDWFDPHRTEG-PAAYLBSLSA-N
    2.1.4 Canonical SMILES
    CC12CCC(=NOCCN)CC1C(=O)CC3C2CCC4(C3CCC4=O)C
    2.1.5 Isomeric SMILES
    C[C@]12CC/C(=N\OCCN)/C[C@@H]1C(=O)C[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C
    2.2 Other Identifiers
    2.2.1 UNII
    W40687GO3S
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 3-((2-aminoethoxy)imino)androstane-6,17-dione

    2. 3-((2-aminoethoxy)imino)androstane-6,17-dione Hydrochloride

    3. Pst 2744

    4. Pst-2744

    5. Pst2744

    2.3.2 Depositor-Supplied Synonyms

    1. 203737-93-3

    2. Istaroxime, (e)-

    3. Pst-2744

    4. W40687go3s

    5. (3e,5s,8r,9s,10r,13s,14s)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione

    6. 203738-46-9

    7. 3-((2-aminoethoxy)imino)-5alpha-androstan-6,17-dione

    8. Debio-0614

    9. Istaroxime [inn]

    10. Unii-w8i9h2tppl

    11. Pst 2744

    12. St-2744

    13. W8i9h2tppl

    14. Unii-w40687go3s

    15. Chembl469045

    16. Schembl7285904

    17. Dtxsid20870222

    18. Akos024259258

    19. Cs-1531

    20. Db06157

    21. Ac-36855

    22. As-78198

    23. Hy-15718

    24. 5-alpha-androstan-6,17-dione, 3-((2-aminoethoxy)imino)-

    25. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5alpha)-

    26. Androstane-3,6,17-trione, 3-(o-(2-aminoethyl)oxime), (3e,5.alpha.)-

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 360.5 g/mol
    Molecular Formula C21H32N2O3
    XLogP31.5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count3
    Exact Mass360.24129289 g/mol
    Monoisotopic Mass360.24129289 g/mol
    Topological Polar Surface Area81.8 Ų
    Heavy Atom Count26
    Formal Charge0
    Complexity645
    Isotope Atom Count0
    Defined Atom Stereocenter Count6
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in heart disease.

    5 Pharmacology and Biochemistry
    5.1 Mechanism of Action

    Reduces the sodium-potassium adenosine triphosphatase (ATPase) activity and stimulates the sarcoplasmic calcium ATPase isoform 2 reuptake function.

    Post Enquiry
    POST ENQUIRY